Dr. Reddy's Laboratories Ltd, FTO-7
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of breast cancer, colorectal cancer (colon cancer), and stomach cancer.
Dosage form: tablets, film-coated
Active substance Dosage capecitabine 150 mg ATC: L01BC06
-
The drug is used for the treatment of breast cancer, colorectal cancer (colon cancer), and stomach cancer.
Dosage form: tablets, film-coated
Active substance Dosage capecitabine 500 mg ATC: L01BC06
-
The drug is used for the treatment of multiple myeloma (as part of combination therapy or as monotherapy depending on the stage of the disease) and mantle cell lymphoma.
Dosage form: lyophilisate for solution for injection
Active substance Dosage bortezomib 3.5 mg ATC: L01XG01
-
The drug is prescribed for the treatment of multiple myeloma (both as part of combination therapy and as monotherapy, depending on the stage), as well as for the treatment of mantle cell lymphoma.
Dosage form: lyophilisate for solution for injection
Active substance Dosage bortezomib 1.0 mg ATC: L01XG01
-
The drug is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior course of anti-tumor therapy. It is used in combination with daratumumab and dexamethasone, lenalidomide and dexamethasone, or with dexamethasone alone.
Dosage form: powder for solution for infusion
Active substance Dosage carfilzomib 60 mg ATC: L01XG02
-
It is used for the treatment of adults and children aged 10 years and older with highly active relapsing-remitting multiple sclerosis, particularly in cases where previous treatment has been ineffective or in cases of rapidly progressing severe disease.
Dosage form: capsules, hard
Active substance Dosage fingolimod 0.5 mg ATC: L04AA27
-
The drug is used for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
-
The drug is prescribed for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
-
The drug is used for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
-
The drug is used for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
-
The drug is intended for the treatment of adult men with metastatic castration-resistant prostate cancer. It is used in cases where the disease has an asymptomatic or mild course and chemotherapy is not indicated, as well as in cases of disease progression following previous docetaxel chemotherapy. Teronred is taken in combination with prednisone or prednisolone.
Dosage form: tablets, film-coated
Active substance Dosage abiraterone 250 mg ATC: L02BX03
-
The drug is intended for the treatment of adult patients with multiple myeloma. It is used in combination with other medicinal products (bortezomib and dexamethasone or dexamethasone alone) depending on the patient's previous treatment experience.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 1 mg ATC: L04AX06
-
The drug is intended for the treatment of adult patients with multiple myeloma. It is used in combination with other medicinal products (bortezomib and dexamethasone or dexamethasone alone) depending on the patient's previous treatment experience.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 2 mg ATC: L04AX06
-
The drug is intended for the treatment of adult patients with multiple myeloma. It is used in combination with other medicinal products (bortezomib and dexamethasone or dexamethasone alone) depending on the patient's previous treatment experience.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 3 mg ATC: L04AX06
-
The drug is intended for the treatment of adult patients with multiple myeloma. It is used in combination with other medicinal products (bortezomib and dexamethasone or dexamethasone alone) depending on the patient's previous treatment history.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 4 mg ATC: L04AX06